Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive perspective. Proponents often emphasize the opportunity for substantial therapeutic benefits, especially in diseases where conventional treatments have proven ineffective. However, crucially important to assess the considerable financial burden associated with CPI